His stories explore how tech is changing the practice of health care and the business and policy challenges to realizing tech’s promise. He’s also the co-author of the free, twice weekly STAT Health ...

Sequel Med Tech announced today that it agreed to integrate its twiist automated insulin delivery system with a future Abbott ...

Medtronic anticipates the separation of its diabetes business unit into a wholly separate entity to complete within 18 months ...

In the coming years the continuous glucose monitoring systems products market is expected to reach USD12,835.6 million by ...

Medtronic (NYSE:MDT) announced today that it intends to separate its Diabetes business into a new standalone company.

Medtronic plans to separate from its diabetes business and launch it as an independent company—one that will count more than ...

CEO Geoff Martha told investors the split simplifies Medtronic’s portfolio, while creating a stand-alone diabetes tech ...

Medtronic announced plans to spin off its once-strained but now-growing diabetes business into an independent company, allowing the medtech giant to focus on high-growth markets such as pulsed field ...

Introduction. Blood glucose monitors are medical devices used to determine the blood glucose level needed for the effective management of ...

In the past 5 years, what change has had the greatest impact on HbA1c in diabetes care? Is it continuous glucose monitoring?

Current labeling advises matching the inhaled insulin units to the injected mealtime dose of rapid-acting insulin analog.

In earnings calls, diabetes tech companies had less to say about tariffs and focused more on future growth.